Thiogenesis Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Thiogenesis Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-15.0%
Buyback Yield
| Total Shareholder Yield | -15.0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're Keeping An Eye On Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate
Nov 20
We Think Thiogenesis Therapeutics (CVE:TTI) Needs To Drive Business Growth Carefully
Jul 17Here's Why We're Not Too Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation
Aug 25We're Not Very Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate
May 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if TTI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TTI's dividend payments have been increasing.
Dividend Yield vs Market
| Thiogenesis Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TTI) | n/a |
| Market Bottom 25% (CA) | 1.8% |
| Market Top 25% (CA) | 6.1% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (TTI) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate TTI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TTI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate TTI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TTI has not reported any payouts.